Update diabetes 1997

Medizinische Klinik

Volumn 92, Issue 11, 1997, Pages 655-662

  Pfeiffer, Andreas ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; INSULIN;

DIABETES CONTROL; DIABETES MELLITUS; GENETIC ANALYSIS; HUMAN; MARKER GENE; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS;

EID: 0030828194     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03044822     Document Type: Article

References (47)

1. Barnett, A. T., C. Eff. R. D. G. Leslie, D. A. Pyke: Diabetes in identical twins. A study of 200 pain. Diabetologia 20(1981), 87-93.
2. Beato, M.: Gene regulation by steroid hormones. Cell 56 (1989), 335-344.
3. Bieg, S., J. Seiner, W. A. Sclierbanni: Zytopla-.in.itiHhe Inselzellantikorper und G AD- Antikörper in der Piabetesdiapiostik. MeJ. Khn. y (ITC). 5')4-59S.
4. Clamen.J. O., T. Hansen. C. IljorKiek et al.: Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 346 (1995), 397-4H2.
5. Clement. K., C. Vaisse, U. S. Manning et al.: Genetic variation in the beta 3-adreneriiic receptor and an increased capacity Eu aîn weight in patients witli niorbiJ obesity [see conmients]. NW Engl.J. Med. 333 (1995), 352-354.
6. Cook. J. T., A. T. ( Lmersley, P. Christopher et al.: Linkage analysis of gtucokinase gène with NIDI )M in C.HICaMan pedigrees. 1 Diabetes 41(1992). 1496-1500 .
7. The Diabetes Control and CoinplicJtionsTri.il Research Group: The etîect of intensive treatment of diabetes on the development and progression oflong-tenn complications in insulin-dependent diabetes mcllitus. New Engl.J. Med. 329 (1993). 977-9S6.
8. Faj.ms. S. S.: MODY diabetes. Diab. Metab. Rev. 5 (19S9).579-6Mf,.
9. Froguel. P., M. Vaxillaire. F. Sun et al.: Clow linkage of glucokinae locus on chromosome 7p to early-onset non-insu lin-dependent diabetes mellitus Nature (Lond.) 356 (1992), 1 62-1
10. Erratum: Nature (Lond.) 337 ( 1992), 607.
11. Ht. Fujikawa, T., H. Ikcgami, E. YamatoetaL: Associât ion of Trp64Arg mutation of the bcta3-adrenergic-receptor vvith NIDDM and body weight gain. Diabetologia 39 (1996), 349-352.
12. Cf etuith, S.: Exogenous insulin administration and cardiovascular risk in non-insulm-dependent and insulin-dependent diabetes mellitus. Ann. Intern. Med. 124 (1996), 104-11)9.
13. Gucobino.J. P.: lieu 3-aJrenoceptor: an update. F.urop. J. Eudocr. 132 (1995), 377-385.
14. Groop, L., A. Miettinen, P. H. Groop. S. Men. S. Koskimies, G. F. lïotuzzo: Orgjn-spccmc autoiinniunity and H LA-1 )R antigens as markers for ben-cell destruction in patients u ith type II diabetes. 1 )i,ibetes 37 ( 1988), V9-103.
15. J him. C. L., E. Boerwinkle, R. Chakraborty et a.: A genome-wide search for huimn non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat. Genet. 13(1996), 161-166.
16. Hitman. G. A., K. Hawrami.M. 1. McCarthy et al.: Insulin receptor substrate-1 gene mutations in NID1XM; implications for the study of polygenic disease. Diabetologia 3S(1995).4XI-JS6.
17. Humphreys, P., M. McCarthy, J. Tuomilehto et al.: Chromosome 4q locus associated with insulin resistance in I'inu Indians. Studies in three European NMDDM populations. Diabetes 43 (1994), 800-804.
18. Kaneko, T.: Troçlitazone (CS-045): A new antidiabetic a&'iu. Honn. Metab. Res. 29 (1997), 2d3-213.
19. Knowler, R., D.J. IVttit. M. F. Saad. IM I. Uenett: Diabetes mellitus in the Pima indians: incidence, risk factors and pathogenesis. Oiab. Metab. Rev. 6 (1990), 1-27.
20. Kobberling,J.,H.Tillil: Empirical risk figures for tlie firstdegree relatives of non-insulin-dependent diabetics. In: Köbberling. J., R. Tattersall (eds.): The genetics of diabetes mellitus. Academic Press, London 1982, p. 201-209.
21. Köbberling, J., R. C. Turner (eds.): New developments in the genetics of type 2- (non-insulin-dependent) diabetes mellitus. Int. Sympos. preceding30th Annual Meeting of the EASD, Düsseldorf 1994.
22. Krolewski. A. S., L. M. B. Litïel, M. Kroleski. M. Quinn. J. 11. Warram: Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. New Engl. J. Med. 332 (1W5), 1251-1255.
23. Kuehnle, 11. P.: New therapeutic agents for the treatment of NIDDM. Exp. Clin. Endocr. Diab. 104 (199C.). 93-HI I.
24. Kuraluyashi, T., 1 ). G. P. Carey, N. A. Morrison: The β3adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women. Diabetes 45 (1996), 135S-I363.
25. McCanhy, M. L.P. Froguel.C;. A. Hitman: The genetics of non-insulin-dependent diabetes mellitus: tools and aims. Diabetologi.137 (1994). 959-9C.S.
26. Nauck, M. A., M. M. Heimesaat, C. Orskov.J.J. IloKt, R, Eben, W. Crcutzfeldt: Presen'ed incretin activity of glucagon-hke peptide 1 [7-36 amide] but not ofs\ mhctic human gastric inhibitory polypeptide in patients with type-2 diabetes inelliius.J. clin. Invest. 91 (1993). 301-307.
27. Nauck, M. A.,J.J. I lolst, B. WilInis. W. Schmiegel: Glucagon-like peptide I (GLP-1) as a new therapeutic approach for type 2-diabetes. Exp. Clin. Endocr. (in press).
28. Piutzner, A., E. Küstner, T. Forst et al.: Intensive insulin therapy with insulin lispro in patients with tjpe 1 diabetes reduces the frequency of hypoglycémie episodes. Exp. clin. Endocr. 104 (1996). 25-30.
29. S. Poller. W., H. Schatz: Molecular genetic analysis of NIDDM. Exp. clin. Endocr. KM (1993), 5S-6S.
30. Prochazkj, M., S. Lillioja.J. F. Tait et al.: Linkage ofchromosomal Tnarkers on 4q with a putative gene determining maximal insulin action in Pinia indians. Diabetes 42 (1993), 514-519.
31. Risch. N., K. MerikatiLMs: Genetic analysis of complex dishes. Science 275 (1997), 1329-1330.'
32. Risen, N., K. Menkangas:The future of genetic studies of complex huin.in diseases. Science 273 (1996), 15161517.
33. Roll, U., A.-G. Ziegler: Combined antibody screening for improved prediction of IDD.M - modem stratèges. Exp. din. Endocr. 105 (1997), 1-14.
34. Shimokawa, K., H. Kadowaki, H. Sakura et al.: Molecular scanning of the glycogen synthase and insulin receptor substrate-1 genes in Japanese subjects with non-insuhndependent diabetes mellitm. liiochcin. liiophys. Res. Commun. 202 (1994). 463-469.
35. Stimkard, A. J., T. I. Sorensen, C. Hanis et al.: An adoption study of human obesity. New Engl.J. Med. 314 (19S6), 193-19S.
36. Susulic, S., R. C. Frederich, J. A. Lawitts ft al.: Knockout of the p3-adrenergic receptor gene (abstract). Program and Abstracts of the 77ih Annual Meeting of the Endocrine Society 1995, p. 36.
37. The 1 )iabetes Control and Complications Trial Research Croup: The absence of a glycémie threshold for the development of long-term complications: The perspective of the diabetes control and complications trial. Diabetes 45 (1996). 12S9-129S.
38. Thompson. R. G.,J. L'efer.on, A. Gottlieb, J. Mullane: Effects of pramlintide, an analog of human amylin, on plasma glucose profiles in patients with iddm. 1 îiabetcs 46 (1997). 632-636.
39. S. ToddJ. A.-.Transcribingdiabetes [news;comment]. Nature (Lond.) 3S4 (1996), 407-108.
40. Toilone, E., S. Pampanelli, C. Lalli et a.: Effects of the short-acting insulin analog (lys(H2S). Pro(B29)) on postprandial blood glucose control in iddni. Diab. Care 19 (1V96). 945-952.
41. 4n. Tuomi, T., L. C. Groop, P. Z. Zimmet, M. J. Rowley, W. Knowles, I. R. Mackay: Antibodies to glutamic acid decarbo.xv läse reveal latent autoimmune diabetes mellitus in adults with a non-imulin-dependent onset of disease. Diabète-; 42 (1993), 359-362.
42. Urlummer, S. A.,J. O. Clauscn,T. I lansen, O. Pedersen: Insulin sensitivit)-and body weight ch.uiges in \ount; white carriers of the codon 64 amino acid polymoq-thism of the beta 3-adrenergic receptor gene. Diabetes 45 (1996), 1115-1120.
43. Walston, J., K. Silver, C. liogardus et al.: Time of onset of non-insii]jn-dependeiit diabetes mellitus and genetic variation in the beta 3-adrenergic-receptorgene [see comments). New Engl.J. Med. 333 (1995), 343-347.
44. Widen. E., M. Lehto, T. Kannmen.J. Walston, A. R. Shuldiner, L. C. Groop: Association of a polymorphism in the β3-adrenergic receptor gene with features of the insulin resistance syndrom in Finns. New Engl.J. Med. 333 (1995),34S-35l'.
45. Yaimgata, K., H. Fumta, N. Oda et al.: Mutations in the hepatoc\ te nuclear factor-4 alpha gene in maturity-onset diabetes of the young (MODY1). Nature {Lond.) 3S4 (1996),45S-460.
46. Yamagata, K., N. Oda, P. J. Kaisaki et al.: Muatations in the hepatocyte nuclear factor-] alpha gene in maturityonsi-t diabetes of the \oung (MODY3). Nature (Lond.) 384(1996), 455-457.
47. Zimmet, P. Z., T. Tuomi, 1. R. Mackay et al.: Latent autoimmune diabetes mellitus in adults (LAI )A): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction ofinsulin dependency. Diab. Med. 11 (1994), 299-303.